L. Eccersley

Bronchoscopy in haematopoietic stem cell transplant recipients may not be beneficial

L. Eccersley, 2007 .

Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia.

S. Mustjoki, H. Dombret, M. Höglund, 2008, Blood.

Cessation of Ciprofloxacin Prophylaxis in Hemato-Oncology Patients

S. Montoto, L. Drumright, S. Agrawal, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

central nervous system Philadelphia chromosomepositive leukemia Dasatinib crosses the blood-brain barrier and is an efficient therapy for

S. Mustjoki, H. Dombret, M. Höglund, 2009 .

International multicenter retrospective analysis of thiotepa-based autologous stem cell transplantation for secondary central nervous system lymphoma

T. Calimeri, E. Nicholson, A. Ferreri, 2022, Haematologica.

Reduced intensity allogeneic hematopoietic stem cell transplantation is a safe and effective treatment option in high‐risk myeloma patients – a single centre experience

J. Gribben, J. Cavenagh, M. Grantham, 2021, British journal of haematology.

Current views of haemolytic streptococcal pathogenesis

S. Sriskandan, L. Tan, L. Eccersley, 2014, Current opinion in infectious diseases.

Thrombotic microangiopathy in untreated myeloma patients receiving carfilzomib, cyclophosphamide and dexamethasone on the CARDAMON study

M. Chapman, J. Cavenagh, R. Benjamin, 2021, British journal of haematology.